Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41(11):1183–1194. doi:10.1002/cac2.12207
   PubMed Web of Science ®Google Scholar
• D&apos G, Eredita M, Martellotta T, Natale F, Ferrarese A. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer. 2001;37:591–596. doi:10.1016/S0959-8049(00)00435-4
   PubMed Web of Science ®Google Scholar
• Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412–424. doi:10.5306/wjco.v5.i3.412
   PubMedGoogle Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–771. doi:10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015;36(2):243–248. doi:10.1093/carcin/bgu247
   PubMed Web of Science ®Google Scholar
• Peng RR, Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for predicting survival in nasopharyngeal carcinoma. J Inflamm Res. 2021;14:4019–4033. doi:10.2147/JIR.S322475
   PubMed Web of Science ®Google Scholar
• Liang RF, Li JH, Li M, Yang Y, Liu YH. The prognostic role of controlling nutritional status scores in patients with solid tumors. Clin Chim Acta. 2017;474:155–158. doi:10.1016/j.cca.2017.09.021
   PubMed Web of Science ®Google Scholar
• Li YX, Chang JY, He MY, et al. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) predict clinical outcome in patients with stage IIB cervical cancer. J Oncol. 2021;2021:2939162. doi:10.1155/2021/2939162
   PubMed Web of Science ®Google Scholar
• Guo W, Lu X, Liu Q, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals. Cancer Med. 2019;8(9):4135–4148. doi:10.1002/cam4.2281
   PubMed Web of Science ®Google Scholar
• Tiainen S, Rilla K, Hamalainen K, Oikari S, Auvinen P. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype. Breast Cancer Res Treat. 2021;185(1):63–72. doi:10.1007/s10549-020-05925-7
   PubMed Web of Science ®Google Scholar
• Xie Z, Zhou H, Wang L, Wu Y. The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the Prognosis of Colon Cancer: a retrospective study. PeerJ. 2022;10:e13091. doi:10.7717/peerj.13091
   PubMed Web of Science ®Google Scholar
• Zhou B-F. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245–252.
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL. AJCC Cancer Staging Manual. 8th ed. Springe: NewYork; 2017.
   Google Scholar
• Benjamin MAF, Fallara G, Ploussard G, Pradere B. Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma. Curr Opin Urol. 2022;32(5):500–503. doi:10.1097/MOU.0000000000001012
   PubMed Web of Science ®Google Scholar
• Gao S, Wu M, Chen Y, et al. Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapy. Future Oncol. 2018;14(14):1377–1386. doi:10.2217/fon-2017-0556
   PubMed Web of Science ®Google Scholar
• Feng JF, Wang L, Yang X, Jiang YH. Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma. Cancer Manag Res. 2019;11:7243–7251. doi:10.2147/CMAR.S208320
   PubMed Web of Science ®Google Scholar
• Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The regulation and function of lactate dehydrogenase a: therapeutic potential in brain tumor. Brain Pathol. 2016;26(1):3–17. doi:10.1111/bpa.12299
   PubMed Web of Science ®Google Scholar
• Smith H, Board M, Pellagatti A, Turley H, Boultwood J, Callaghan R. The effects of severe hypoxia on glycolytic flux and enzyme activity in a model of solid tumors. J Cell Biochem. 2016;117(8):1890–1901. doi:10.1002/jcb.25488
   PubMed Web of Science ®Google Scholar
• Mishra D, Banerjee D. Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment. Cancers. 2019;11:6. doi:10.3390/cancers11060750
   Web of Science ®Google Scholar
• Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y. Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018;7(12):6124–6136. doi:10.1002/cam4.1820
   PubMed Web of Science ®Google Scholar
• Ding J, Karp JE, Emadi A. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark. 2017;19(4):353–363. doi:10.3233/CBM-160336
   PubMed Web of Science ®Google Scholar
• Saito H, Kono Y, Murakami Y, et al. Postoperative serum albumin is a potential prognostic factor for older patients with gastric cancer. Yonago Acta Med. 2018;61(1):72–78. doi:10.33160/yam.2018.03.010
   PubMed Web of Science ®Google Scholar
• Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. 1998;32(6 Suppl 4):S118–S125. doi:10.1016/S0272-6386(98)70174-X
   PubMedGoogle Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:10.1186/1475-2891-9-69
   PubMed Web of Science ®Google Scholar
• Gan W, Zhang MX, Wang JX, et al. Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child-Pugh I who underwent curative resection: a prognostic nomogram study. Cancer Manag Res. 2018;10:5383–5394. doi:10.2147/CMAR.S176317
   PubMed Web of Science ®Google Scholar
• Nakazawa N, Sohda M, Yamaguchi A, et al. An elevated serum lactate dehydrogenase-to-albumin ratio is a useful poor prognostic predictor of nivolumab in patients with gastric cancer. Anticancer Res. 2021;41(8):3925–3931. doi:10.21873/anticanres.15188
   PubMed Web of Science ®Google Scholar
• Sabrkhany S, Griffioen AW, Oude Egbrink MG. The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta. 2011;1815(2):189–196. doi:10.1016/j.bbcan.2010.12.001
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148. doi:10.1016/j.immuni.2004.07.017
   PubMed Web of Science ®Google Scholar
• Azab B, Shah N, Radbel J, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol. 2013;30(1):432. doi:10.1007/s12032-012-0432-4
   PubMed Web of Science ®Google Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R
   PubMed Web of Science ®Google Scholar
• Al Jarroudi O, El Bairi K, Abda N, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med. 2021;15(14):1289–1298. doi:10.2217/bmm-2020-0717
   PubMed Web of Science ®Google Scholar
• Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110(10):2524–2530. doi:10.1038/bjc.2014.163
   PubMed Web of Science ®Google Scholar
• Hua X, Duan F, Zhai W, et al. A novel inflammatory-nutritional prognostic scoring system for patients with early-stage breast cancer. J Inflamm Res. 2022;15:381–394. doi:10.2147/JIR.S338421
   PubMed Web of Science ®Google Scholar
• Sahin AB, Cubukcu E, Ocak B, et al. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Sci Rep. 2021;11(1):14662. doi:10.1038/s41598-021-94184-7
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.21388
   PubMed Web of Science ®Google Scholar
• Salive ME, Cornoni-Huntley J, Phillips,CL, et al. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol. 1992;45(3):213–221. doi:10.1016/0895-4356(92)90081-W
   PubMed Web of Science ®Google Scholar
• Ribelles N, Perez-Villa L, Jerez JM, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res. 2013;15(5):R98. doi:10.1186/bcr3559
   PubMed Web of Science ®Google Scholar